Table 3.
Statistical analysis of the presence of other risk factors and comorbidities in Acute CVS patients with HTN and Acute CVS non-hypertensive patients.
| Parameter | CVS-HTN (n = 91) |
CVS-NHTN (n = 90) |
P-value Chi-square (χ2) |
|||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Diabetic | Yes | 27 | 29.68% | 10 | 11.11% | 0.053 |
| No | 64 | 70.32% | 80 | 88.89% | ||
| Smoking | Yes | 31 | 34.06% | 49 | 59.3% | 0.269 |
| No | 60 | 65.94% | 41 | 40.7% | ||
| H/O Stroke | Yes | 12 | 13.18% | 12 | 13.33% | 0.998 |
| No | 79 | 86.82% | 78 | 86.67% | ||
| Atherosclerosis | Yes | 39 | 42.86% | 32 | 35.55% | 0.133 |
| No | 52 | 57.14% | 58 | 54.45% | ||
| Carotid stenosis | Yes | 10 | 10.98% | 15 | 16.67% | 0.281 |
| No | 81 | 89.02% | 75 | 83.33% | ||
| AF | Yes | 13 | 14.28% | 9 | 10.00% | 0.301 |
| No | 78 | 85.72% | 81 | 90.00% | ||
| IHD | Yes | 41 | 45.06% | 10 | 11.12% | 0.003∗ |
| No | 50 | 54.94% | 80 | 88.88% | ||
| RHD | Yes | 3 | 3.30% | 11 | 12.22% | 0.071 |
| No | 88 | 96.70 | 79 | 87.78% | ||
| Valve Replacement | Yes | 1 | 1.10% | 2 | 2.22% | 0.853 |
| No | 90 | 98.90% | 88 | 97.78 | ||
CVS-HTN, cerebrovascular stroke in hypertensive patients; CVS-NHTN, cerebrovascular stroke in non-hypertensive patients; H/O stroke, history of stroke, AF, atrial fibrillation, IHD, ischemic heart diseases; RHD, rheumatic heart diseases.